XML 126 R110.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes - Other (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:      
Net operating loss carryforwards $ 26,586 $ 33,800  
Research and development credits 1,238 1,769  
Operating lease liabilities 1,604 1,803  
Returns and discounts 45,774 18,528  
Stock-based compensation 7,621 7,570  
Accruals and other 8,791 6,257  
Capitalized R&D 468 707  
Intangible assets 37,928 32,771  
Deferred royalty obligation 28,712    
Gross deferred tax assets: 158,722 103,205  
Valuation allowance (6,498) (5,781)  
Total deferred tax assets: 152,224 97,424  
Deferred tax liabilities:      
Debt discount (45) (344)  
Operating lease assets (1,372) (1,529)  
Intangible assets (49,964) (65,774)  
Property and equipment (2,810) (3,518)  
Total deferred tax liabilities: (54,191) (71,165)  
Net deferred tax assets 98,033 26,259  
Valuation allowance      
Valuation allowance 6,498 5,781  
Allowance increased the tax 431 527  
Deferred tax asset valuation allowance increase 717   $ 0
Change in valuation allowance 287    
Net operating loss carryforwards      
Deferred tax benefit 26,814 2,153 8,391
Reconciliation of gross unrecognized tax benefits - Federal, State and Foreign Tax      
Gross UTB Balance as of beginning of period 11,306 11,400 654
Additions for tax positions related to acquisitions     10,930
(Reductions) additions for tax positions of prior years   (94) (184)
Gross UTB Balance as of end of period 11,306 11,306 11,400
Net UTB impacting the effective tax rate at December 31 excluding valuation allowance impacts, if any 11,275 11,275 $ 11,368
BioDelivery Sciences International, Inc      
Net operating loss carryforwards      
Net operating losses acquired 234,675    
Operating loss estimated to expire unbenefited due to IRC 382 annual limitations 90,062    
Ironshore      
Net operating loss carryforwards      
Net operating losses acquired 1,092    
U.S. federal      
Net operating loss carryforwards      
Net operating losses 102,148 137,459  
Net operating loss carryforwards - subject to expiration 60,160    
Net operating loss carryforwards - no expiration 41,988    
Research and development tax credit carryforwards, net 1,025 1,025  
State      
Net operating loss carryforwards      
Net operating losses 198,986 202,381  
Research and development tax credit carryforwards, net $ 0 $ 672